CD19 and Stroke: There were no significant differences in CD19+ B lymphocytes or GL-7+ germinal center B lymphocytes (Fig. 7A,B), or in IgG1 and IgA isotypes (Fig. 7C), between the spleens of vehicle- and HPβCD-treated mice at 7 weeks after stroke.